SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-016537
Filing Date
2024-02-23
Accepted
2024-02-23 16:42:29
Documents
15
Period of Report
2024-02-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea193234-6k_mainzbiomed.htm   iXBRL 6-K 19488
2 MAINZ BIOMED USA, INC. CARVE-OUT PLAN ea193234ex99-1_mainzbiomed.htm EX-99.1 40220
  Complete submission text file 0001213900-24-016537.txt   213269

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mynz-20240223.xsd EX-101.SCH 2655
4 XBRL LABEL FILE mynz-20240223_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE mynz-20240223_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT ea193234-6k_mainzbiomed_htm.xml XML 1801
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 24672104
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)